(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 9.22% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Mckesson's revenue in 2025 is $359,051,000,000.On average, 7 Wall Street analysts forecast MCK's revenue for 2026 to be $50,770,201,185,039, with the lowest MCK revenue forecast at $50,346,552,512,220, and the highest MCK revenue forecast at $51,113,094,788,897. On average, 6 Wall Street analysts forecast MCK's revenue for 2027 to be $54,686,404,217,325, with the lowest MCK revenue forecast at $54,085,881,999,340, and the highest MCK revenue forecast at $55,391,440,693,224.
In 2028, MCK is forecast to generate $58,503,712,783,114 in revenue, with the lowest revenue forecast at $58,323,908,859,157 and the highest revenue forecast at $58,753,397,145,592.